Lederer Ann-Kathrin, Staubitz-Vernazza Julia I, Margies Rabea, Wild Florian, Musholt Thomas J
Section of Endocrine Surgery, Department of General, Visceral and Transplantation Surgery, University Medical Center Mainz, Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.
Center for Complementary Medicine, Department of Medicine II, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Cancers (Basel). 2024 Feb 29;16(5):1007. doi: 10.3390/cancers16051007.
Thyroid surgery is associated with a risk of injury to the recurrent laryngeal nerve, especially in the presence of anatomical variants such as a non-recurrent laryngeal nerve (NRLN). Injury to the nerve leads to transient or permanent vocal cord palsy (VCP). A novel method to prevent VCP is continuous intraoperative nerve monitoring (cIONM), but less is known about the applicability of this method in patients with NRLN. The aim of this study was to evaluate our own data regarding feasibility and detailed characteristics of cIONM in NRLN patients. We performed a monocentric retrospective cohort analysis including clinical data and intraoperative nerve monitoring data (measured by Inomed Medizintechnik GmbH, Emmendingen, 'C2' and 'C2 Xplore' device) of all thyroid surgery patients, showing NRLN between 2014 and 2022. Of 1406 patients who underwent thyroid surgery with cIONM between 2014 and 2022, 12 patients (0.9%) showed NRLN intraoperatively. Notably, cIONM was feasible in eight patients (67%). In all cases the onset latency of the right vagus nerve was shorter (<3.0 ms) than usually expected, suggesting that a short latency might be suitable to distinguish NRLN. None of the patients had a post-operative VCP. Overall, cIONM appears to be feasible and safe in NRLN patients and provides helpful information to prevent VCP.
甲状腺手术存在损伤喉返神经的风险,尤其是在存在诸如非喉返神经(NRLN)等解剖变异的情况下。神经损伤会导致暂时性或永久性声带麻痹(VCP)。一种预防VCP的新方法是术中连续神经监测(cIONM),但对于该方法在NRLN患者中的适用性了解较少。本研究的目的是评估我们自己关于cIONM在NRLN患者中的可行性和详细特征的数据。我们进行了一项单中心回顾性队列分析,纳入了2014年至2022年间所有甲状腺手术患者的临床数据和术中神经监测数据(由伊诺美医疗技术有限公司,埃门丁根,“C2”和“C2 Xplore”设备测量),这些患者术中显示有NRLN。在2014年至2022年间接受cIONM甲状腺手术的1406例患者中,有12例(0.9%)术中显示有NRLN。值得注意的是,cIONM在8例患者(67%)中是可行的。在所有病例中,右迷走神经的起始潜伏期均短于通常预期(<3.0毫秒),这表明短潜伏期可能适合于鉴别NRLN。所有患者术后均未发生VCP。总体而言,cIONM在NRLN患者中似乎是可行且安全的,并为预防VCP提供了有用信息。